The stock of Port Erin Biopharma Investments Ltd (LON:PEBI) is a huge mover today! The stock decreased 6.08% or GBX 0.36 on November 7, hitting GBX 5.64. About 15,000 shares traded hands. Port Erin Biopharma Investments Ltd (LON:PEBI) has risen 31.43% since April 7, 2016 and is uptrending. It has outperformed by 29.47% the S&P500.
The move comes after 9 months negative chart setup for the GBX 1.34 million company. It was reported on Nov, 7 by Barchart.com. We have GBX 5.02 PT which if reached, will make LON:PEBI worth GBX 147,400 less.
Another recent and important Port Erin Biopharma Investments Ltd (LON:PEBI) news was published by Prnewswire.com which published an article titled: “Bontan changes its name to Portage Biotech Inc. and jurisdiction to BVI” on July 31, 2013.
Port Erin Biopharma Investments Limited invests in the biotechnology and biopharmaceutical sector. The company has a market cap of 1.34 million GBP. The Firm focuses on creating value for shareholders through investing in companies that have the potential to generate revenues through the development of biopharmaceutical drugs. It currently has negative earnings. The Firm invests in equity and equity-related products in both quoted companies, which offer the benefits of liquidity, and in unquoted companies, which offers the additional capital gains upon completion of an Initial Public Offering .
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.